Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Granulation Size Distribution

Posted on By

SOP for Granulation Size Distribution

Procedure for Granulation Size Distribution Analysis

1) Purpose

The purpose of this SOP is to outline the procedure for determining the size distribution of granules used in pharmaceutical manufacturing to ensure consistency and quality in the final product.

2) Scope

This SOP applies to all granulation batches prepared for tablet or capsule production within the manufacturing facility.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting size distribution testing and ensuring compliance with this SOP.
Production Department: Responsible for providing granule samples for testing and maintaining granulation process parameters.

4) Procedure

4.1 Sampling:
    4.1.1 Collect representative samples of granules from various points within the granulator according to the sampling plan.
    4.1.2 Ensure samples are taken from different depths and locations to obtain a uniform representation.

See also  SOP for Ash Content Determination

4.2 Equipment Preparation:
    4.2.1 Calibrate the sieving equipment as per the manufacturer’s instructions.
    4.2.2 Ensure all sieves are clean and free from previous residues.

4.3 Sieving Procedure:
    4.3.1 Weigh an appropriate amount of the granule sample (e.g., 100 grams).
    4.3.2 Place the sample on the top sieve of a nested set of sieves arranged by decreasing mesh size.
    4.3.3 Operate the sieve shaker for a specified period (e.g., 10 minutes) at a set amplitude.
    4.3.4 After sieving, weigh the granules retained on each sieve and the pan.

4.4 Calculation:
    4.4.1 Calculate the percentage of granules retained on each sieve.
    4.4.2 Plot the granule size distribution curve to assess the distribution.

See also  In-Process Control: SOP for Elemental Impurity Testing

4.5 Acceptance Criteria:
    4.5.1 The granulation is acceptable if the size distribution falls within the specified range (e.g., 20% retained on 30 mesh, 40% on 40 mesh, 30% on 60 mesh, 10% on pan).

4.6 Documentation:
    4.6.1 Document all weights and calculations in the Granulation Size Distribution Record.
    4.6.2 Review and approve the documentation by QC Manager.

5) Abbreviations, if any

QC: Quality Control

6) Documents, if any

Granulation Size Distribution Record
Calibration Record for Sieving Equipment
Sampling Plan Document

7) Reference, if any

21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

See also  In-Process Control: SOP for Tablet Hardness TestingĀ 

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Personal Hygiene for Manufacturing Staff
Next Post: Capsule Formulation: SOP for pH Testing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version